Pleomorphic Variant Mantle Cell Lymphoma Active Not Recruiting Phase 2 Trials for Cyclophosphamide (DB00531)

IndicationStatusPhase
DBCOND0119590 (Pleomorphic Variant Mantle Cell Lymphoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02427620Ibrutinib, Rituximab, and Consolidation Chemotherapy in Treating Young Patients With Newly Diagnosed Mantle Cell LymphomaTreatment